Publications:

Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology

Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W

Publication Date: 2022

Variant appearance in text: PIK3CA: 882T>C; Y294Y

PubMed Link: 36238300

Variant Present in the following documents:

• Table_1.xlsx, sheet 4

View BVdb publication page

EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine

Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W

Publication Date: 2022-09-19

Variant appearance in text: PIK3CA: 882T>C; Y294Y

PubMed Link: 36123678

Variant Present in the following documents:

• 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.

The Journal Of Neuroscience : The Official Journal Of The Society For Neuroscience

Gross, Christina C; Nakamoto, Mika M; Yao, Xiaodi X; Chan, Chi-Bun CB; Yim, So Y SY; Ye, Keqiang K; Warren, Stephen T ST; Bassell, Gary J GJ

Publication Date: 2010-08-11

Variant appearance in text: PI3K: Y294=

PubMed Link: 20702695

Variant Present in the following documents:

• Main text

View BVdb publication page

Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling.

Cardiovascular Research

White, Gemma E GE; Tan, Thomas C C TC; John, Alison E AE; Whatling, Carl C; McPheat, William L WL; Greaves, David R DR

Publication Date: 2010-03-01

Variant appearance in text: PI3K: Y294=

PubMed Link: 19840952

Variant Present in the following documents:

• Main text

View BVdb publication page